# An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

> clinical trial · VERIFIED · 2026-07-16

Status: ENROLLING_BY_INVITATION · Sponsor: Biogen · Condition: Systemic Lupus Erythematosus (SLE)

- Company: Biogen
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT05352919

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.